Targeting the Central Histamine H₂ Receptor: New Hope for Schizophrenia?

Neurosci Bull. 2024 Jan;40(1):143-145. doi: 10.1007/s12264-023-01122-w. Epub 2023 Sep 21.

Authors

Wenkai Lin¹, Xuemin Yu², Xinyan Zhu²

Affiliations

¹ Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Zhejiang Chinese Medical University, Hangzhou, 310053, China. 21719009@zju.edu.cn.
² Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, Zhejiang Chinese Medical University, Hangzhou, 310053, China.

PMID: 37733204
PMCID: PMC10774238 (available on 2025-01-01)
DOI: 10.1007/s12264-023-01122-w

No abstract available

MeSH terms

Histamine*
Humans
Receptors, Histamine H2
Schizophrenia* / drug therapy

Substances

Histamine
Receptors, Histamine H2